# HeartSciences Inc. (HSCS) · Edgar & Edgarette company card

> HeartSciences (HSCS) saw revenue fall 0.7% in FY2026 to $0 million, operating margin -194787% against a -6.4% median for finance services. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1468492 · fiscal year ended 2026-04-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/HSCS) · [JSON](https://www.pops4.com/boards/company/HSCS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $4,319 |
| Revenue growth, 1 year | -0.7% |
| Revenue growth per year | -26.0% |
| Operating margin | -194787.4% (prior year -192013.1%) |
| Net margin | -211666.5% |
| Operating cash flow | −$7M |
| Capital spending | $3,554 |
| Free cash flow | −$7M |
| Cash | $2M |
| Long-term debt | — |
| Total assets | — |
| Total equity | $226,060 |
| Equity ÷ assets | — |
| Return on equity | -4044.0% |
| Dividend per share | $0 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$7.4M in FY2026); operating loss: a margin of -194787.4% in FY2026; revenue is hard to predict: its 80% range is ±91%

## Edgarette's reading

Exposure: revenue $4K (FY2026). Experience: revenue down 0.7% on the year, down 26.0% a year over 4 years; operating margin -194787.4%, down from -192013.1%. Soundness: return on equity -4044.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1K and $19K next year (method v4.1: its own 3-year record of growth weighed at 40% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1K to $23K. A statistical range, not company guidance. Against peers (36 filers, $50M+ revenue, finance services): operating margin -194787.4% against a -6.4% median; growth -0.7% against 16.8%.

Range logged 2026-09-29, receipt fa16026d33ee8cce, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-08-07 ([filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026086773/0001213900-26-086773-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-07-10 ([filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026077218/0001213900-26-077218-index.htm))

## Recent filings

- 8-K · filed 2026-10-06 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026107238/0001213900-26-107238-index.htm)
- 8-K · filed 2026-10-02 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026106500/0001213900-26-106500-index.htm)
- 8-K · filed 2026-09-17 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026100752/0001213900-26-100752-index.htm)
- 8-K · filed 2026-09-15 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/0001213900-26-100185-index.htm)
- 10-Q · filed 2026-09-14 · [filing](https://www.sec.gov/Archives/edgar/data/1468492/000143774926030319/0001437749-26-030319-index.htm)
- 8-K · filed 2026-08-20 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1468492/000121390026091893/0001213900-26-091893-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001468492.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1468492

## Cite

POPS4, Edgar & Edgarette: HeartSciences Inc. (HSCS) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/HSCS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.